Dr Erick Michael Brown, DO | |
8900 State Line Rd, Ste. 380, Leawood, KS 66206-1960 | |
(913) 385-7252 | |
(913) 385-2412 |
Full Name | Dr Erick Michael Brown |
---|---|
Gender | Male |
Speciality | Psychiatry |
Experience | 16 Years |
Location | 8900 State Line Rd, Leawood, Kansas |
Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1689834335 | NPI | - | NPPES |
A91A00003 | Other | KS | MEDICARE PTAN |
A91B00005 | Other | MO | MEDICARE PTAN |
A91000011 | Other | MO | MEDICARE PTAN |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
2084P0800X | Psychiatry & Neurology - Psychiatry | 05-35325 (Kansas) | Primary |
2084P0800X | Psychiatry & Neurology - Psychiatry | 2012007494 (Missouri) | Secondary |
Group Practice Name | Group PECOS PAC ID | No. of Members |
---|---|---|
Psychiatry Associates Of Kansas City Pa | 4688563869 | 12 |
Psychiatry Associates Of Kansas City Pa | 4688563869 | 12 |
News Archive
Rush University Medical Center is among the first hospitals in the nation, and the only one in Illinois, to provide patients fighting advanced kidney access to a new combination immunotherapy that targets different immune system cells and processes than a widely used therapy that has been proven effective for some patients but had little effect on others.
Compared with ipilimumab, treatment with pembrolizumab not only significantly improves outcomes, but also results in fewer high-grade adverse events in patients with advanced melanoma, a phase III trial shows.
Aridis Pharmaceuticals, Inc., a biopharmaceutical company applying proprietary technologies to produce novel therapies for infectious diseases, announced today the initiation of a Phase 1 clinical study of Aerucin, the Company's fully human IgG1 monoclonal antibody (mAb) against Pseudomonas aeruginosa bacteria, which is being developed as an adjunctive treatment for acute pneumonia.
AstraZeneca and its global biologics research and development arm, MedImmune, today announced that the US Food and Drug Administration has approved FASENRA (benralizumab) for the add-on maintenance treatment of patients with severe asthma aged 12 years and older, and with an eosinophilic phenotype.
› Verified 4 days ago
Entity Name | Psychiatry Associates Of Kansas City Pa |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1356321947 PECOS PAC ID: 4688563869 Enrollment ID: O20041027000555 |
News Archive
Rush University Medical Center is among the first hospitals in the nation, and the only one in Illinois, to provide patients fighting advanced kidney access to a new combination immunotherapy that targets different immune system cells and processes than a widely used therapy that has been proven effective for some patients but had little effect on others.
Compared with ipilimumab, treatment with pembrolizumab not only significantly improves outcomes, but also results in fewer high-grade adverse events in patients with advanced melanoma, a phase III trial shows.
Aridis Pharmaceuticals, Inc., a biopharmaceutical company applying proprietary technologies to produce novel therapies for infectious diseases, announced today the initiation of a Phase 1 clinical study of Aerucin, the Company's fully human IgG1 monoclonal antibody (mAb) against Pseudomonas aeruginosa bacteria, which is being developed as an adjunctive treatment for acute pneumonia.
AstraZeneca and its global biologics research and development arm, MedImmune, today announced that the US Food and Drug Administration has approved FASENRA (benralizumab) for the add-on maintenance treatment of patients with severe asthma aged 12 years and older, and with an eosinophilic phenotype.
› Verified 4 days ago
Mailing Address | Practice Location Address |
---|---|
Dr Erick Michael Brown, DO 8900 State Line Rd, Ste. 380, Leawood, KS 66206-1960 Ph: (913) 385-7252 | Dr Erick Michael Brown, DO 8900 State Line Rd, Ste. 380, Leawood, KS 66206-1960 Ph: (913) 385-7252 |
News Archive
Rush University Medical Center is among the first hospitals in the nation, and the only one in Illinois, to provide patients fighting advanced kidney access to a new combination immunotherapy that targets different immune system cells and processes than a widely used therapy that has been proven effective for some patients but had little effect on others.
Compared with ipilimumab, treatment with pembrolizumab not only significantly improves outcomes, but also results in fewer high-grade adverse events in patients with advanced melanoma, a phase III trial shows.
Aridis Pharmaceuticals, Inc., a biopharmaceutical company applying proprietary technologies to produce novel therapies for infectious diseases, announced today the initiation of a Phase 1 clinical study of Aerucin, the Company's fully human IgG1 monoclonal antibody (mAb) against Pseudomonas aeruginosa bacteria, which is being developed as an adjunctive treatment for acute pneumonia.
AstraZeneca and its global biologics research and development arm, MedImmune, today announced that the US Food and Drug Administration has approved FASENRA (benralizumab) for the add-on maintenance treatment of patients with severe asthma aged 12 years and older, and with an eosinophilic phenotype.
› Verified 4 days ago
Sasha G Hamdani, M.D. Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 8900 State Line Road, Suite 380, Leawood, KS 66206 Phone: 913-385-7252 Fax: 913-385-2412 | |
Dr. Awni A Gayed, M.D Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 10965 Granada Ln, 201, Leawood, KS 66211 Phone: 913-685-8387 Fax: 913-317-8193 | |
Steven Deane Segraves, MD Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 8900 State Line Rd, Ste 380, Leawood, KS 66206 Phone: 913-385-7252 Fax: 913-385-2412 | |
Dr. Douglas L Geenens, DO Psychiatry & Neurology Medicare: Not Enrolled in Medicare Practice Location: 4901 W 136th St, Leawood, KS 66224 Phone: 913-488-2012 Fax: 913-890-7285 | |
Christopher Robert Vanhorn, DO Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 8900 State Line Rd, Ste 380, Leawood, KS 66206 Phone: 913-385-7252 Fax: 913-385-2412 | |
Michael Joseph Everson, MD Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 8900 State Line Rd, Ste 380, Leawood, KS 66206 Phone: 913-385-7252 Fax: 913-385-2412 | |
Waghi B Silwance, M.D Psychiatry & Neurology Medicare: Not Enrolled in Medicare Practice Location: 11100 Ash St, Leawood, KS 66211 Phone: 913-345-1155 Fax: 913-345-0818 |